Elicio Therapeutics Stock Last Dividend Paid

ELTX Stock   5.24  0.21  4.17%   
Elicio Therapeutics fundamentals help investors to digest information that contributes to Elicio Therapeutics' financial success or failures. It also enables traders to predict the movement of Elicio Stock. The fundamental analysis module provides a way to measure Elicio Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elicio Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Elicio Therapeutics Company Last Dividend Paid Analysis

Elicio Therapeutics' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

 = 

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

Elicio Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for Elicio Therapeutics is extremely important. It helps to project a fair market value of Elicio Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Elicio Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Elicio Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Elicio Therapeutics' interrelated accounts and indicators.
0.08-0.910.620.08-0.920.970.440.180.090.930.790.070.130.790.83-0.59
0.080.03-0.34-0.49-0.240.16-0.11-0.970.990.23-0.380.42-0.36-0.380.3-0.67
-0.910.03-0.82-0.420.96-0.91-0.14-0.280.0-0.74-0.860.21-0.3-0.86-0.880.65
0.62-0.34-0.820.73-0.70.64-0.010.5-0.260.460.86-0.720.780.860.49-0.31
0.08-0.49-0.420.73-0.270.18-0.60.51-0.44-0.20.39-0.850.60.390.210.07
-0.92-0.240.96-0.7-0.27-0.95-0.11-0.01-0.26-0.8-0.730.09-0.2-0.73-0.940.79
0.970.16-0.910.640.18-0.950.250.090.180.870.71-0.020.160.710.86-0.61
0.44-0.11-0.14-0.01-0.6-0.110.250.22-0.120.650.430.42-0.010.43-0.02-0.01
0.18-0.97-0.280.50.51-0.010.090.22-0.960.010.59-0.40.390.59-0.070.49
0.090.990.0-0.26-0.44-0.260.18-0.12-0.960.25-0.330.33-0.26-0.330.29-0.69
0.930.23-0.740.46-0.2-0.80.870.650.010.250.70.190.140.70.66-0.59
0.79-0.38-0.860.860.39-0.730.710.430.59-0.330.7-0.340.541.00.55-0.35
0.070.420.21-0.72-0.850.09-0.020.42-0.40.330.19-0.34-0.9-0.340.12-0.16
0.13-0.36-0.30.780.6-0.20.16-0.010.39-0.260.140.54-0.90.54-0.110.05
0.79-0.38-0.860.860.39-0.730.710.430.59-0.330.71.0-0.340.540.55-0.35
0.830.3-0.880.490.21-0.940.86-0.02-0.070.290.660.550.12-0.110.55-0.8
-0.59-0.670.65-0.310.070.79-0.61-0.010.49-0.69-0.59-0.35-0.160.05-0.35-0.8
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition

Elicio Dividend Paid And Capex Coverage Ratio

Dividend Paid And Capex Coverage Ratio

(470.6)

At this time, Elicio Therapeutics' Dividend Paid And Capex Coverage Ratio is fairly stable compared to the past year.
Based on the recorded statements, Elicio Therapeutics has a Last Dividend Paid of 0.0. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Elicio Last Dividend Paid Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elicio Therapeutics' direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elicio Therapeutics could also be used in its relative valuation, which is a method of valuing Elicio Therapeutics by comparing valuation metrics of similar companies.
Elicio Therapeutics is currently under evaluation in last dividend paid category among its peers.

Elicio Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Elicio Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Elicio Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

Elicio Fundamentals

About Elicio Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Elicio Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elicio Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elicio Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Elicio Stock Analysis

When running Elicio Therapeutics' price analysis, check to measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.